Filters
Other countries
Results: 1 to 15 of 15
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Centogene AG - the Rare Disease Company Germany | 218 | 135 |
|
Centogene AG - the Rare Disease Company Germany | 74 | 34 |
|
PDGFRB - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 5 | 1 |
|
Invitae Leukodystrophy and Genetic Leukoencephalopathy Panel Invitae United States | 971 | 680 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
Invitae Overgrowth Syndromes Panel Invitae United States | 96 | 53 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Parkinson's disease panel. NGS panel of 22 genes. Genologica Medica Spain | 45 | 22 |
|
Dystonia panel. NGS panel of 20 genes. Genologica Medica Spain | 35 | 20 |
|
Duzen Laboratories Duzen BBAGUAS Turkey | 4 | 1 |
|
Vascular Anomalies (VANseq) Expanded Del/Dup Panel Seattle Children's Hospital Genetics Laboratories Seattle Children's United States | 50 | 47 |
|
Vascular Anomalies (VANseq) Expanded Sequencing Panel Seattle Children's Hospital Genetics Laboratories Seattle Children's United States | 50 | 47 |
|
Infantile myofibromatosis: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 2 | 2 |
|
Infantile Myofibromatosis Type 1 , Sequencing PDGFRB Gene Reference Laboratory Genetics Spain | 1 | 1 |
|
Basal ganglia calcification Panel CeGaT GmbH Germany | 52 | 27 |
|
Results: 1 to 15 of 15
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.